tiprankstipranks
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
AAPG
Ascentage Pharma Group International Unsponsored ADR
RESEARCH TOOLSreports
Want to see AAPG full AI Analyst Report?

Ascentage Pharma Group International Unsponsored ADR (AAPG) Ratios

26 Followers

Ascentage Pharma Group International Unsponsored ADR Ratios

AAPG's free cash flow for Q2 2025 was ¥0.91. For the 2025 fiscal year, AAPG's free cash flow was decreased by ¥ and operating cash flow was ¥-2.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.79 1.26 1.44 1.86 5.22
Quick Ratio
 1.77 1.26 1.42 1.85 5.21
Cash Ratio
 1.50 1.06 1.14 1.67 4.73
Solvency Ratio
 -0.44 -0.13 -0.34 -0.35 -0.45
Operating Cash Flow Ratio
 0.15 -0.10 -0.78 -0.74 -1.67
Short-Term Operating Cash Flow Coverage
 0.20 -0.14 -1.20 -1.28 -15.19
Net Current Asset Value
¥ 315.01M¥ -869.49M¥ -1.09B¥ -785.12M¥ 179.96M
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.64 0.72 0.63 0.37
Debt-to-Equity Ratio
 1.49 6.32 29.72 4.39 0.88
Debt-to-Capital Ratio
 0.60 0.86 0.97 0.81 0.47
Long-Term Debt-to-Capital Ratio
 0.36 0.77 0.95 0.76 0.45
Financial Leverage Ratio
 2.99 9.91 41.39 6.93 2.38
Debt Service Coverage Ratio
 -0.90 -0.30 -1.05 -1.39 -13.24
Interest Coverage Ratio
 -46.34 -5.74 -9.08 -16.10 -51.99
Debt to Market Cap
 0.14 0.17 0.20 0.22 0.15
Interest Debt Per Share
 21.67 22.95 26.80 28.00 17.30
Net Debt to EBITDA
 0.44 -1.82 -0.98 -0.40 0.78
Profitability Margins
Gross Profit Margin
84.09%97.03%86.24%89.51%88.08%
EBIT Margin
-210.42%-33.73%-376.97%-397.87%-2921.96%
EBITDA Margin
-196.00%-24.23%-334.98%-375.26%-2860.39%
Operating Profit Margin
-210.42%-37.70%-393.11%-405.23%-3116.57%
Pretax Profit Margin
-215.56%-40.31%-420.24%-423.05%-2981.90%
Net Profit Margin
-216.74%-41.34%-416.98%-421.02%-2803.38%
Continuous Operations Profit Margin
-216.78%-41.37%-417.02%-421.02%-2803.38%
Net Income Per EBT
100.55%102.58%99.23%99.52%94.01%
EBT Per EBIT
102.44%106.90%106.90%104.40%95.68%
Return on Assets (ROA)
-31.03%-15.49%-37.02%-31.20%-26.61%
Return on Equity (ROE)
-123.61%-153.46%-1532.08%-216.05%-63.37%
Return on Capital Employed (ROCE)
-51.46%-25.48%-55.72%-43.60%-33.73%
Return on Invested Capital (ROIC)
-33.71%-16.58%-39.67%-34.28%-31.11%
Return on Tangible Assets
-31.76%-16.11%-38.73%-32.45%-27.41%
Earnings Yield
-8.65%-4.23%-10.63%-11.17%-11.13%
Efficiency Ratios
Receivables Turnover
 2.24 9.90 1.36 3.41 0.52
Payables Turnover
 0.85 0.32 0.42 0.23 0.05
Inventory Turnover
 3.15 4.41 1.89 2.33 0.85
Fixed Asset Turnover
 0.68 1.08 0.23 0.32 0.03
Asset Turnover
 0.14 0.37 0.09 0.07 <0.01
Working Capital Turnover Ratio
 0.58 2.73 0.38 0.18 0.02
Cash Conversion Cycle
 -153.16 -1.03K -403.64 -1.32K -6.63K
Days of Sales Outstanding
 162.69 36.88 268.90 107.02 707.86
Days of Inventory Outstanding
 115.70 82.79 193.20 156.77 431.02
Days of Payables Outstanding
 431.56 1.15K 865.74 1.59K 7.77K
Operating Cycle
 278.40 119.66 462.10 263.79 1.14K
Cash Flow Ratios
Operating Cash Flow Per Share
 2.62 -1.47 -10.29 -9.92 -9.50
Free Cash Flow Per Share
 2.54 -1.80 -11.09 -13.52 -16.36
CapEx Per Share
 0.08 0.32 0.81 3.59 6.86
Free Cash Flow to Operating Cash Flow
 0.97 1.22 1.08 1.36 1.72
Dividend Paid and CapEx Coverage Ratio
 31.31 -4.58 -12.77 -2.76 -1.38
Capital Expenditure Coverage Ratio
 31.31 -4.58 -12.77 -2.76 -1.38
Operating Cash Flow Coverage Ratio
 0.12 -0.07 -0.40 -0.36 -0.56
Operating Cash Flow to Sales Ratio
 0.43 -0.11 -3.27 -3.12 -21.67
Free Cash Flow Yield
1.65%-1.42%-8.99%-11.27%-14.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.75 -23.63 -9.40 -8.95 -8.98
Price-to-Sales (P/S) Ratio
 25.57 9.77 39.22 37.68 251.79
Price-to-Book (P/B) Ratio
 10.91 36.26 144.09 19.34 5.69
Price-to-Free Cash Flow (P/FCF) Ratio
 61.70 -70.62 -11.12 -8.87 -6.75
Price-to-Operating Cash Flow Ratio
 59.50 -86.02 -11.99 -12.08 -11.62
Price-to-Earnings Growth (PEG) Ratio
 0.06 0.26 4.50 -0.98 4.03
Price-to-Fair Value
 10.91 36.26 144.09 19.34 5.69
Enterprise Value Multiple
 -12.60 -42.13 -12.68 -10.44 -8.02
Enterprise Value
 13.80B 10.01B 9.43B 8.22B 6.40B
EV to EBITDA
 -12.40 -42.13 -12.68 -10.44 -8.02
EV to Sales
 24.30 10.21 42.49 39.19 229.48
EV to Free Cash Flow
 58.64 -73.80 -12.05 -9.23 -6.15
EV to Operating Cash Flow
 56.77 -89.90 -12.99 -12.57 -10.59
Tangible Book Value Per Share
 13.44 2.30 -0.56 4.55 18.06
Shareholders’ Equity Per Share
 14.31 3.50 0.86 6.20 19.40
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.03 <0.01 <0.01 0.06
Revenue Per Share
 6.13 12.99 3.15 3.18 0.44
Net Income Per Share
 -13.29 -5.37 -13.12 -13.39 -12.29
Tax Burden
 1.01 1.03 0.99 1.00 0.94
Interest Burden
 1.02 1.19 1.11 1.06 1.02
Research & Development to Revenue
 1.97 0.97 3.18 3.54 27.46
SG&A to Revenue
 0.98 0.39 0.82 0.81 5.14
Stock-Based Compensation to Revenue
 0.07 0.02 0.14 0.11 1.68
Income Quality
 -0.14 0.28 0.78 0.74 0.73
Currency in CNY